Company profile
Kimer Med company profile
Kimer Med is developing a family of broad-spectrum antiviral therapeutics. Our first targets are the Dengue virus and pandemic preparedness. We closed our Series A capital raise in Oct 2024.
Business identity
- Website
- https://kimermed.co.nz
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2020-08-13
Headquarters
- Headquarters
- Valvatna, Vestland, Norway
- Country code
- NO
- Continent
- Europe